O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis
- PMID: 8341657
- PMCID: PMC46953
- DOI: 10.1073/pnas.90.14.6468
O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis
Abstract
We previously generated transgenic C3H/HeN mice by introducing the Escherichia coli O6-methylguanine-DNA methyltransferase (MGMT, DNA-O6-methylguanine:protein-L-cysteine S-methyltransferase, EC2.1.1.63) gene, ada, attached to the Chinese hamster metallothionein I gene promoter. One transgenic mouse line expressing both ada-specific mRNA and Ada protein could be propagated over many generations in a homozygous state with respect to the integrated DNA. Liver extracts from transgenic homozygous mice have consistently demonstrated about 3 times the control activity of normal mice. Furthermore, in the transgenic homozygotes treated with ZnSO4, activity is increased to 6-8 times the normal level in mice and is equivalent to that for man. To examine whether these increased levels of MGMT activity can actually decrease the susceptibility of animals to N-nitroso compounds, we studied liver carcinogenesis in our transgenic mice expressing high amounts of MGMT. Groups of transgenic and nontransgenic mice, each comprising about 200 suckling animals (14 +/- 1 days old), were divided each into eight subgroups, providing paired groups of transgenic and nontransgenic mice. They received an i.p. injection of ZnSO4 to induce MGMT, and 10 hr thereafter were given an i.p. injection of either dimethylnitrosamine or diethylnitrosamine. Liver tumor development was quantitatively assessed at 7-11 months. Here, we report statistically significant reduction of tumor formation in transgenic mice of four of the six paired groups that received treatment. The remaining two demonstrated results in line with dose dependence. Therefore, our data indicate that MGMT can indeed protect animals from low-dose exposure to environmental alkylating carcinogens.
Similar articles
-
Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene.Cancer Res. 1991 Jul 1;51(13):3391-8. Cancer Res. 1991. PMID: 2054779
-
Enhanced O6-methylguanine-DNA methyltransferase activity in transgenic mice containing an integrated E. coli ada repair gene.Mutat Res. 1989 Nov;218(3):197-206. doi: 10.1016/0921-8777(89)90004-9. Mutat Res. 1989. PMID: 2530449
-
Characterization of O6-methylguanine-DNA methyltransferase in transgenic mice introduced with the E. coli ada gene.Mutat Res. 1991 May;254(3):225-30. doi: 10.1016/0921-8777(91)90060-3. Mutat Res. 1991. PMID: 2052012
-
Health span and life span in transgenic mice with modulated DNA repair.Ann N Y Acad Sci. 2001 Apr;928:132-40. doi: 10.1111/j.1749-6632.2001.tb05643.x. Ann N Y Acad Sci. 2001. PMID: 11795504 Review.
-
Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies.Mutat Res. 2001 Jun 2;477(1-2):41-9. doi: 10.1016/s0027-5107(01)00094-x. Mutat Res. 2001. PMID: 11376685 Review.
Cited by
-
Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors.Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6941-6. doi: 10.1073/pnas.93.14.6941. Proc Natl Acad Sci U S A. 1996. PMID: 8692923 Free PMC article.
-
Sex and Alkyladenine DNA Glycosylase Expression are Key Susceptibility Factors for NDMA-induced Mutations, Toxicity, and Cancer.bioRxiv [Preprint]. 2025 May 16:2025.05.13.653839. doi: 10.1101/2025.05.13.653839. bioRxiv. 2025. PMID: 40463078 Free PMC article. Preprint.
-
Temporal cell-type-specific mRNA expression of O6-methylguanine-DNA methyltransferases in liver of rats treated with dimethylnitrosamine.Am J Pathol. 1996 Feb;148(2):497-507. Am J Pathol. 1996. PMID: 8579112 Free PMC article.
-
Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition.Cancer Res. 2013 May 1;73(9):2897-904. doi: 10.1158/0008-5472.CAN-12-3980. Epub 2013 Feb 25. Cancer Res. 2013. PMID: 23440427 Free PMC article.
-
Balancing repair and tolerance of DNA damage caused by alkylating agents.Nat Rev Cancer. 2012 Jan 12;12(2):104-20. doi: 10.1038/nrc3185. Nat Rev Cancer. 2012. PMID: 22237395 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials